Skip to main content
Clinical Trials/NCT01477658
NCT01477658
Unknown
Not Applicable

Effects of Chronic Right Ventricular Pacing in Children With Advanced Atrioventricular Block

University of Sao Paulo1 site in 1 country140 target enrollmentNovember 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Congenital Complete Atrioventricular Heart Block
Sponsor
University of Sao Paulo
Enrollment
140
Locations
1
Primary Endpoint
Mortality
Last Updated
12 years ago

Overview

Brief Summary

Recent studies have shown that chronic stimulation of the right ventricle can cause deleterious effects to cardiac function and synchronicity. The occurrence and consequences of this phenomenon in children and young patients with cardiac pacemaker due to advanced atrioventricular block (AVB) are still unknown.

Thus, our aims is to assess the chronic effects of cardiac pacing in children and young patients with advanced AVB and its impact on clinical, functional and echocardiographic parameters.

Detailed Description

This is a prospective cohort study that will include patients younger than 18 years-old at initial pacemaker implantation due to advanced AVB. The design of the study will involve the following stages: 1. Screening and enrollment: patients will be selected consecutively during ambulatory care at our Institution or by the database of the Surgical Unity of Cardiac Pacing; 2. Clinical and laboratory evaluation: patient history, clinical evaluation, serum levels of neurohormonal and inflammatory biomarkers of heart failure, clinical and laboratory investigation of autoimmune rheumatic diseases, quality of life (SF-36, CHQ-PF50) and six-minute walk test; 3. Evaluation of ventricular function and cardiac synchronicity: Tissue Doppler (TDI) and real-time three-dimensional echocardiography (RT3DE); 4. Follow-up: patients will be monitored during 24 months. The main end-points are: * Clinical and functional changes (NYHA functional class) * Heart failure hospitalization * Quality of life * Overall and cardiac mortality * Cardiac resynchronization therapy and heart transplantation

Registry
clinicaltrials.gov
Start Date
November 2007
End Date
November 2013
Last Updated
12 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Roberto Costa

Associated Professor of Cardiovascular Surgery

University of Sao Paulo

Eligibility Criteria

Inclusion Criteria

  • Age \<18 years at initial pacemaker implantation
  • Advanced AV block with /without congenital heart defects
  • Time under cardiac pacing superior than one year
  • Unicameral or atrioventricular pacing in single right ventricle site
  • Informed consent of the patient or responsible

Exclusion Criteria

  • Bifocal or biventricular pacing
  • Discontinuing use of the device for recovery of atrioventricular conduction
  • Cardiac transplantation
  • Inability to participate in the study procedures

Outcomes

Primary Outcomes

Mortality

Time Frame: 24 months after enrollment

Secondary Outcomes

  • Echocardiogram and Clinical Composite(baseline and 24 months after enrollment)

Study Sites (1)

Loading locations...

Similar Trials